Evidence map›Paper›PMID 38003573›Full record

ArticleInternational journal of molecular sciences2023

Jamie M L Kok, Georgina C Dowd, Jaydee D Cabral, Lyn M Wise

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Jamie M L KokDepartment of Pharmacology and Toxicology, School of Biomedical Sciences, University of Otago, Dunedin 9054, New Zealand.
Georgina C DowdThe New Zealand Institute for Plant and Food Research Limited, Nelson 7043, New Zealand.
Jaydee D CabralDepartment of Microbiology and Immunology, School of Biomedical Sciences, University of Otago, Dunedin 9054, New Zealand.ORCID 0000-0002-5620-0330
Lyn M WiseDepartment of Pharmacology and Toxicology, School of Biomedical Sciences, University of Otago, Dunedin 9054, New Zealand.ORCID 0000-0003-0646-8424
University of Otago · NZPlant & Food Research · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Atopic dermatitis is a chronic condition where epidermal barrier dysfunction and cytokine production by infiltrating immune cells exacerbate skin inflammation and damage. A total lipid extract from

Indexed as

Dermatitis, AtopicMacrocystisClaudin-1CytokinesHumansInterleukin-13KeratinocytesLipidsTumor Necrosis Factor-alphaClaudin-1CytokinesInterleukin-13LipidsTumor Necrosis Factor-alphaatopic dermatitisbrown seaweedchemokinecytokineepidermal barrierinflammationkeratinocytelipidMacrocystis pyriferatight junction

Identifiers

PMID38003573
PMCPMC10671590
OpenAlexW4388732686

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.